Another way to increase tumor immunogenicity is by causing upregulation of tumor-specific markers, for example 5-FU and cisplatin were shown to cause increase in tumor-antigen expression in cancer lines in vitro, leading to increased recognition and killing by antigen-specific CD8 T cell lines [103]. The gene discussed is CD8A; the disease is neoplasm.